Joint Corp. price target lowered to $16 from $20 at Lake Street

Lake Street analyst Ryan Meyers lowered the firm’s price target on Joint Corp. (JYNT) to $16 from $20 and keeps a Buy rating on the shares. The firm believes The Joint continues to make positive strides in its corporate clinic transition following its first quarter 2025 results, but is trimming its price target based on a lower 2026 EBITDA estimate.